FDA Considers Leucovorin for Autism Treatment
TL;DR Summary
The F.D.A. announced it will relabel leucovorin, a form of folate, to reflect its potential benefits in reducing autism symptoms in children, highlighting ongoing research into folate's role in various health conditions.
- F.D.A. to Relabel Leucovorin for Autism Treatment The New York Times
- The drug Trump plans to promote for autism shows real (and fragile) hope The Washington Post
- What is leucovorin? Researchers mixed on Trump, RFK Jr.'s potential answer to autism USA Today
- Cancer drug could double as autism therapy, and is poised for FDA approval Fox News
- FDA to approve drug to treat autism symptoms Politico
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 1 min read
Condensed
82%
173 → 32 words
Want the full story? Read the original article
Read on The New York Times